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Bisphenol A and phthalate esters are used as additives in the manufacture of
plastic materials, but their ability to leach out with age and heat has resulted
in their becoming ubiquitous contaminants of the ecosystem including within
human body tissues. Over recent years, these compounds have been shown to
possess endocrine disrupting properties with an ability to interfere in the
actions of many hormones and to contribute to human health problems. Much
of the reported disruptive activity has been in relation to the action of estro-
gens, androgens, and thyroid hormones, and concerns have been raised for
adverse consequences on female and male reproductive health, thyroid func-
tion, metabolic alterations, brain development/function, immune responses,
and development of cancers in hormone-sensitive tissues. A recurring theme
throughout seems to be that there are windows of susceptibility to exposure in
utero and in early postnatal life, which may then result in disease in later life
without any need for further exposure. This commentary highlights key issues
in a historical context and raises questions regarding the many data gaps.
KEYWORD S
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1 | INTRODUCTION
An endocrine disruptor is defined as “an exogenous
substance that causes adverse health effects in an intact
organism, and/or its progeny, consequent to changes in
endocrine function”. (Weybridge report, 1996 )
Normal growth, development, and maintenance of
multicellular organisms are dependent on a functional
endocrine system. However, over recent years, many
environmental chemicals, including bisphenol A (BPA)
and phthalate esters used as additives in the manufacture
of plastic materials, have been shown to possess the
ability to interfere in hormone action. Such endocrine-
disrupting chemicals (EDCs) may act by altering hor-
mone synthesis in the endocrine gland, by altering trans-
port/metabolism/excretion of the hormone, or by
competing with physiological hormone for binding to
receptors in target cells and in so doing to mimic inap-
propriately or antagonize hormone actions (Figure 1)
(Darbre, 2015). Much of the reported disruptive activity
of BPA and the phthalate esters have been in relation to
the action of estrogens, androgens, and thyroid hor-
mones, and concerns have been raised for adverse conse-
quences on human health ranging from female and male
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reproductive health, to thyroid function, to metabolic
alterations underlying diabetes, cardiovascular disease,
and obesity, to impaired brain development/function and
compromised immune responses, and to cancers in
hormone-sensitive tissues (Figure 2) (Darbre, 2015). Win-
dows of susceptibility for EDC exposure appear to be
most notably in utero and in early postnatal life, with
consequences of such exposures often not visible until
later in adult life and sometimes even carried into future
generations (Darbre, 2015).
Plastics are made as organic polymers mixed with a












FIGURE 1 Mechanisms by
which endocrine-disrupting
chemicals (EDCs) may interfere
in hormone action. EDCs, such
as bisphenol A (BPA) and
phthalates, may interfere in
hormone (H) synthesis in the
endocrine gland, in the transport
of the hormone around the
bloodstream and in the hormone
actions at target tissues. They
may also alter the metabolism
































FIGURE 2 Overview of concerns
for human health following exposure to
endocrine-disrupting chemicals (EDCs)
such as bisphenol A (Rochester, 2013)
and phthalates (Hauser & Calafat, 2005)
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toughness, flexibility, and color. Their versatility, durabil-
ity, and light weight have resulted in widespread use as
construction materials, in packaging applications, and in
household and medical products. BPA is used for its
cross-linking properties as an additive in polycarbonate
plastics and epoxy resins to harden the product for use as
food storage containers and water bottles. Phthalates are
esters of phthalic acid, which are used as plasticizers to
reduce brittleness and increase flexibility especially in
polyvinyl chloride (PVC) plastics but are also added to
many other consumer goods, including adhesives, paints,
air-freshener products, and personal care products. Early
experiments, reporting that BPA could leach out of plas-
tic materials when heated (Krishnan, Stathis, Permuth,
Tokes, & Feldman, 1993), have led to a more general
understanding of the ability of these widely used addi-
tives to leach out of plastic materials with heat and age to
become ubiquitous contaminants of the ecosystem
including human body tissues.
2 | EVIDENCE FOR ENDOCRINE
DISRUPTING PROPERTIES OF BPA
Synthesis of BPA was first described in 1891
(Dianin, 1891) and its estrogenic properties reported in
the 1930s (Dodds & Lawson, 1936). During the 1930s,
chemicals with estrogenic properties were being sought
for their medicinal properties, but more potent estrogens
such as diethylstilboestrol (DES) were adopted in prefer-
ence to the weaker compounds such as BPA. Prescription
of DES to prevent miscarriage (Smith, 1948) was used
until 1971 and use was ceased following the report of rare
vaginal cancers in daughters of mothers who had taken
the drug during pregnancy (Herbst, Ulfelder, &
Poskanzer, 1971). Further studies over the following
decades have revealed the numerous reproductive abnor-
malities and cancers in sons (Palmer et al., 2009) as well
as daughters (Hoover et al., 2011) following exposure in
utero to this potent estrogen and have served as a warn-
ing of the legacy of developmental consequences from in
utero exposures to endocrine-disrupting agents (Harris &
Mainwaring, 2012).
BPA was never used as a drug but instead found its way
into the manufacture of epoxy resin and polycarbonate
plastics, turning it into a high volume production chemical
(OECD, 2004), which has become widely distributed includ-
ing in human tissues and urine (Calafat, Ye, Wong, Reidy, &
Needham, 2008). Its ability to mimic physiological estrogens
derives from its phenolic groupings (Figure 3), which are
now known to determine binding to estrogen receptors
(Brzozowski et al., 1997). In vitro, it has been shown to bind
to estrogen receptors ERα and ERβ, to stimulate estrogen-
dependent gene expression and to increase proliferation of
estrogen-responsive cells (Wetherill et al., 2007), but it can
also act via membrane estrogen receptors including the G-
protein-coupled receptor GPR30 and via non-genomic
mechanisms (Rubin, 2011). It has also been shown able to
FIGURE 3 Chemical structures of bisphenols and phthalate esters in relation to that of the physiological estrogen 17β-oestradiol and
the synthetic estrogen diethylstilboestrol
1302 DARBRE
increase the expression of aromatase, the key enzyme nec-
essary for the conversion of androgens into estrogens
(Williams & Darbre, 2019). In addition to its estrogenic
activity, it can also bind to the androgen receptor and give
antiandrogenic responses (Sohoni & Sumpter, 1998). BPA
can also bind to thyroid hormone receptors and interfere in
thyroid function (Wetherill et al., 2007). Furthermore, BPA
can also bind to and interfere in the actions of peroxisome
proliferator-activated receptors (PPARs) (Gao et al., 2020).
Animal models have demonstrated adverse effects on male
and female reproductive function (Rochester, 2013; Rubin,
2011). Epidemiological studies suggest a link between BPA
exposure in humans and multiple adverse endocrine conse-
quences, including not only male and female reproductive
functions but also alterations to thyroid hormones, immune
function, disruption of glucose homeostasis (diabetes), car-
diovascular disease, and obesity (Rochester, 2013). Exposure
to BPA has also been linked to the development of
hormone-sensitive cancers, most notably breast cancer
(Hafezi & Abdel-Rahman, 2019). Animal models have
shown that exposure to BPA during critical windows of
development of the mammary gland in utero can alter
mammary gland biology and increase the risk of subse-
quent breast cancer in later life (Soto, Brisken, Schaeberie, &
Sonnenschein, 2013).
Due to the endocrine-disrupting properties of BPA,
much effort has been devoted to the development of ana-
logs such as bisphenol F (BPF) and bisphenol S (BPS)
(Figure 3) in the hope that substitutes might be found
without adverse activity. However, models both in vivo
(Mu et al., 2018) and in vitro (Kojima et al., 2019) have
shown that these analogs can still bind to estrogen recep-
tors and give estrogenic responses on gene expression
albeit with some differences in detailed mechanisms of
action at a molecular level, (Li et al., 2018).
3 | EVIDENCE FOR ENDOCRINE
DISRUPTING PROPERTIES OF
PHTHALATES
Phthalates are esters of phthalic acid, which comprise a large
family of compounds derived from the many combinations
of alkyl and aryl ester groupings and producing compounds
from low to high molecular weight (Figure 3). Therefore,
unlike BPA, which is a single compound, the endocrine-
disrupting properties of phthalates are more complex with
different compounds having different potencies and effects.
Di(2-ethylhexyl) phthalate (DEHP) is the main plasticizer
used in PVC due to its low cost. Butylbenzylphthalate (BBP)
is used in the manufacture of foamed PVC for flooring mate-
rials. Diethylphthalate (DEP) is added to many personal care
products to stabilize fragrance. Many of the phthalates are so
widely used that they are now individually listed as high pro-
duction volume chemicals by theOECD (2004). Early studies
in vitro showed that several phthalate esters could bind to
estrogen receptors, stimulate estrogen-dependent gene
expression and increase the growth of estrogen-responsive
cells (Harris, Henttu, Parker, & Sumpter, 1997; Jobling,
Reynolds, White, Parker, & Sumpter, 1995). However, some
phthalate esters can also interfere in the action of PPARs,
which act as lipid sensors in the regulation of lipid homeosta-
sis. Several EDCs have been shown to alter adipogenesis
through interfering in PPARγ actions (Janesick &
Blumberg, 2011). Although many phthalates show greater
responses through PPARα than on PPARγ (Hurst &
Waxman, 2003), the phthalate metabolite mono
(2-ethylhexyl) phthalate is a potent activator of PPARγ
(Maloney&Waxman, 1999) andBBPhas been shown to pro-
mote adipogenesis in 3T3-L1 preadipocytes (Yin, Yu, Lu, &
Yu, 2016). Many in vivo models have demonstrated that in
utero exposure to phthalates impacts negatively on reproduc-
tive development in male rodents with a striking similarity
to the testicular dysgenesis syndrome in humans
(Howdeshell, Hotchkiss, & Gray, 2017), suggesting that
phthalate exposure may adversely impact on male reproduc-
tive health.
4 | SOURCES OF HUMAN
EXPOSURE TO BPA AND
PHTHALATES
Since BPA and phthalates are ubiquitous environmental
pollutants, human exposure may result from inhalation,
ingestion, and dermal absorption. In the air, BPA is now a
ubiquitous pollutant albeit with considerable variation
across different parts of the world, from the highest levels in
urban India (200–17,400 pg/m3), but even detectable in
polar regions (1–17 pg/m3) (Fu & Kawamura, 2010). Corre-
lations have been reported in the air between levels of BPA
and 1,3,5-triphenylbenzene, which is a tracer for plastic
burning, suggesting a source of the atmospheric BPA could
be burning of plastic materials (Fu & Kawamura, 2010).
BPA is also widely present in food, following leaching out
from the plastic packaging (Andujar et al., 2019) and is pre-
sent at low levels in drinking water (Arnold et al., 2013).
Phthalates are ubiquitous in air, especially in the
indoor environment, and in one study in the Richmond
area of the USA were measured as present in 100% of
homes (Rudel et al., 2010). The more volatile phthalates
dimethylphthtalate (DMP), DEP, and dibutylphthalate
(DBP) are present at higher concentrations in the air than
the heavier, less volatile phthalates such as DEHP and
BBP, which are more prevalent in house dust (Heudorf,
Mersch-Sundermann, & Angerer, 2007; Rudel, Camann,
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Spengler, Korn, & Brody, 2003). Higher ambient temper-
atures are associated with higher air concentrations of
phthalates (Uhde, Bednarek, Fuhrmann, & Salthammer,
2001) and the presence of PVC flooring has been associ-
ated with higher levels of DEHP and BBP in house dust
(Bornehag et al., 2004, 2005). Diet is generally considered
as the main route of exposure (Serrano, Braun, Trasande,
Dills, & Sathyanarayana, 2014). However, the dermal
absorption of phthalates from the topical application of
personal care products has also been demonstrated
(Janjua, Frederiksen, Skakkebaek, Wulf, & Andersson,
2008). Phthalate metabolites have been detected in
almost all human urine samples indicating widespread
exposure of the population (Silva et al., 2004). Urinary
concentrations of the main metabolite of DEP have been
positively associated with the use of personal care prod-
ucts, reflecting the use of DEP as a fixative for fragrance
(Philippat, Bennett, Calafat, & Picciotto, 2015).
5 | CONCERNS FOR HUMAN
HEALTH AND THE CONSEQUENCES
OF EARLY LIFE EXPOSURES
Exposure to EDCs, which includes BPA and phthalates,
has long been a matter of concern in relation to human
health (Darbre, 2015) (Figure 2). The reported lack of fer-
tility in farm animals in the 1920–1940s following con-
sumption of plant-based phytoestrogens provided a
warning of the potential for consequences of exposure to
potent estrogenic compounds on human reproductive
health, as did also the many reports of reproductive fail-
ures in wildlife following exposure to pollutant chemicals
with endocrine-disrupting properties (Darbre, 2015). How-
ever, it was the many long-term side-effects of prescription
of DES to women during pregnancy, which brought evi-
dence of the consequences specifically for humans as well
as animals (Harris & Mainwaring, 2012). The link between
fetal development and adult disease, as uncovered in the
mid-1990s (Barker, 1995), brought a new concept of the
possibility of fetal origins of adult disease (Barker, 1995),
and this unfolding legacy of DES showed that exposure to
untoward endocrine agents in utero could have long-term
effects into adult life (Harris & Mainwaring, 2012).
Although endocrine-disrupting agents have been impli-
cated in a wide range of human health problems, a recur-
ring theme throughout seems to be that there are
windows of susceptibility in utero and in early postnatal
life, which may then herald in disease in later life without
any need for further chemical exposure.
Effects of in utero exposure to certain phthalate esters
and consequences for male reproductive health have
been a matter of long-standing research both using
animal models and human epidemiological approaches
(Hauser & Calafat, 2005). Although animal models reveal
a clear link, human epidemiological studies are more
mixed. Such variations from epidemiological research
probably reflect the environmental reality of the com-
plexity of studying mixture effects, not only mixtures of
different esters themselves but also mixtures involving
other EDCs (Howdeshell et al., 2017).
Mouse models have shown that exposure to BPA dur-
ing critical windows of susceptibility during either fetal
(Vandenberg et al., 2007) or early postnatal (Munoz de
Toro et al., 2005) life can lead to altered mammary gland
biology and increased risk of mammary cancers (Soto
et al., 2013). Dose-response studies of mammary budding
showed that the increase in duct and bud growth, which
were stimulated at low concentrations, was inhibited at
higher concentrations (Vandenberg et al., 2006). This is
reflective of the non-monotonic actions of many EDCs
(Vandenberg et al., 2012) and highlighted the ability of
BPA to act in early life at low doses in a different manner
from higher doses and to act adversely at low doses
rather than higher doses. In human epidemiological stud-
ies of breast biology, a positive association has been
reported in postmenopausal women between serum BPA
levels and mammographic breast density (Sprague
et al., 2013), which is a predictive marker of breast cancer
risk (Boyd et al., 2010).
Some EDCs, now termed obesogens, can interfere in
the endocrine regulation of energy metabolism and
development of adipose tissue architecture, most notably
in early life, leading then to weight gain and obesity in
adulthood (Darbre, 2017). Animal models have shown
that early exposure to BPA (vom Saal, Nagel, Coe,
Angle, & Taylor, 2012) or BPS (Ivry Del Moral
et al., 2016) can predispose animals to weight gain, and
transgenerational studies in rodents have further
reported the passing of heritable traits towards obesity
following exposure to BPA and some phthalates (DEHP
and DBP) (Manikkam, Tracey, Guerrero-Bosagna, &
Skinner, 2013). in vitro models have shown that BPA
(Masuno et al., 2002), BBP (Yin et al., 2016), and a
phthalate metabolite (Feige et al., 2007) can promote
adipogenesis in 3T3-L1 preadipocytes. Epidemiological
studies have reported that early-life exposure to BPA is
associated with increased weight gain in children
(Vafeiadi et al., 2016) and have noted an association
between urinary concentrations of phthalate metabolites
and increased waist circumference (Hatch et al., 2008;
Stahlhut, vanWijngaarden, Dye, Cook, & Swan, 2007).
BPA levels have also been found to correlate in adult
humans with circulating levels of leptin and ghrelin
(Rönn et al., 2014), hormones secreted by the adipose tis-
sue to regulate hunger. This suggests that BPA may also
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be able to interfere with hormonal control of hunger and
satiety (Rönn et al., 2014), and this has been supported
by a report of increased production of leptin mRNA in
the 3T3L1 adipocyte model after 3 weeks of exposure to
1 nM BPA (Ariemma et al., 2016).
Other studies are also implicating early life exposure
to EDCs, including these plastics additives, to altered
development of the brain and immune system. Prenatal
exposures to BPA (Mustieles, Perez-Lobato, Olea, &
Fernandez, 2015) and phthalates (Ejaredar, Nyanza,
Eycke, & Dewey, 2015) are being associated with adverse
cognitive and behavioral outcomes in children. Early life
exposures to EDCs are also being reported to suppress
inflammatory processes leading to insufficient immune
responses against bacteria, viruses, fungi, and cancer cells
(Bansal, Henao-Meja, & Simmons, 2018; Nowak,
Jablonska, & Ratajczak-Wrona, 2019). In one rodent
model, exposure of pregnant animals to BPA modulated
the innate immunity of their offspring against the influ-
enza virus type A (Roy, Bauer, & Lawrence, 2012). There-
fore in writing during the global COVID-19 pandemic, it
may also be pertinent to raise the question as to whether
compromise of the immune system by exposure to EDCs,
such as BPA and phthalates, could have impacted also on
susceptibility to infection by SARS-CoV-2 (COVID-19)
coronavirus, and whether differing previous EDC expo-
sures could have contributed to the variation in severity
of symptoms and outcomes for individual people.
6 | FINAL COMMENTS AND
DATA GAPS
Plastics are now ubiquitous in both our indoor and out-
door environments, and the ability of chemical additives
to leach out with age and heat is a particular problem
when these chemicals can interfere with hormonal sys-
tems, which are fundamental to the regulation of the
human body. Of course, like all things, our bodies can
tolerate small levels of such pollutants, but the problems
arise as use increases and exposures rise. And further-
more, this is compounded by the ability of multiple pol-
lutant chemicals to act by similar mechanisms, thus
enabling the BPA and phthalates to feed into an even big-
ger picture of endocrine disruption resulting from expo-
sures to mixtures of low doses of many EDCs over the
long-term (Darbre, 2015). One solution would certainly
be to replace the BPA and phthalate esters with other
compounds lacking the endocrine-disrupting properties,
but so far efforts at finding substitutes have not proved
easy as illustrated by the adverse properties being uncov-
ered for other bisphenol substitutes. With our increasing
dependence on plastic materials, much needs to be done
in educating consumers in ways of avoiding or reducing
their exposures on a daily basis.
Although much has been learned over the past few
decades concerning potential consequences of exposure
to EDCs such as BPA and phthalate esters, more defini-
tive research is needed to give greater clarity of specific
associations and particularly in the assessment of mix-
tures. Adverse effects seem now unlikely to result from
single sources or even single chemicals but rather from
long-term low-dose mixtures of chemicals with additive,
overlapping, or complementary mechanisms of action.
With this in mind, it is all the more imperative to con-
tinue the assessment of the contribution of BPA and
phthalate exposures to human health problems and to
determine the underlying mechanisms of individual
susceptibility.
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